Trials / Completed
CompletedNCT05709002
Smoking, Stress, HIV and Mobile Technology
A Fully Automated and Culturally-Adapted mHealth Intervention for Smoking Cessation Among Black Smokers With HIV
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- University of Houston · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The present investigation aims to address disparities in cigarette use outcomes among Black/African American adults with HIV. The specific aims of this study are: (1) To modify a recently developed, culturally adapted, mobile application for Black smokers by integrating information specifically relevant to Black persons with HIV/AIDS. (2) To conduct a randomized clinical trial for anxiety-sensitivity reduction and cigarette cessation among Black smokers with HIV.
Detailed description
The current trial aims to refine and conduct a comprehensive cultural and HIV-sensitive adaptation of an initially tested, novel mobile intervention (MASP+) targeting anxiety sensitivity (AS) among Black/African American (daily) cigarette users with HIV/AIDS. The MASP+ app prompts users remotely throughout the day to assess mood symptoms, cigarette cravings or nicotine withdrawal symptoms, and general mental health. When respondents indicate they are struggling with cigarette urges or cravings, or if they are experiencing heightened levels of stress or anxiety, the app selects and delivers a tailored message from a library of messages and videos. The MASP+ app has the potential to deliver highly effective and accessible treatment to a highly underserved subpopulation within the Black community considered to be at exceptionally high risk of smoking problems (social, psychological, physical) and smoking relapse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | MASP+ | mHealth (mobile app) for smoking cessation |
| BEHAVIORAL | Control | A mobile app designed to assist the general population with smoking cessation. |
Timeline
- Start date
- 2023-10-16
- Primary completion
- 2025-06-24
- Completion
- 2025-06-24
- First posted
- 2023-02-01
- Last updated
- 2025-07-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05709002. Inclusion in this directory is not an endorsement.